SCHEMBL3519225

SCHEMBL3519225

CC(C)SO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O

nearest known ligand 0.56

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.47
MAPT P10636 1/20 0.46
TYR P14679 3/20 0.43
LGALS1 P09382 2/20 0.43
LGALS3 P17931 2/20 0.43
GAA P10253 1/20 0.43
LGALS9 O00182 1/20 0.43
LGALS8 O00214 1/20 0.43
POLB P06746 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31019382 1.00 L3MBTL1 (0.47) L3MBTL1MAPTTYRLGALS1LGALS3
SCHEMBL3181367 1.00 L3MBTL1 (0.47) L3MBTL1MAPTTYRLGALS1LGALS3
SCHEMBL1020079 0.91 L3MBTL1 (0.43) L3MBTL1MAPTTYRLGALS1LGALS3
SCHEMBL25041163 0.80 L3MBTL1 (0.51) L3MBTL1MAPTTYRLGALS1LGALS3
SCHEMBL29306855 0.80 L3MBTL1 (0.51) L3MBTL1MAPTTYRLGALS1LGALS3
SCHEMBL20053437 0.80 L3MBTL1 (0.51) L3MBTL1MAPTTYRLGALS1LGALS3
SCHEMBL17423690 0.80 LGALS1 (0.50) L3MBTL1MAPTTYRLGALS1LGALS3
SCHEMBL116442 0.80 LGALS1 (0.50) L3MBTL1MAPTTYRLGALS1LGALS3
SCHEMBL5527338 0.80 LGALS1 (0.50) L3MBTL1MAPTTYRLGALS1LGALS3
SCHEMBL11573310 0.78 L3MBTL1 (0.49) L3MBTL1MAPTTYRLGALS1LGALS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9783838-B2 PmST3 enzyme for chemoenzymatic synthesis of alpha-2-3-sialosides THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-10-10 US disclosed
CN-107208118-A The non-natural microorganism of energy efficiency with raising 基因组股份公司 2017-09-26 CN disclosed
CN-104736716-A Microorganisms and methods for enhancing the availability of reducing equivalents in the presence of methanol and producing related 1, 4-butanediol GENOMATICA INC 2015-06-24 CN disclosed
CN-104685058-A Microorganisms and methods for making 4-hydroxybutyrate, 1, 4-butanediol, and related compounds GENOMATICA INC 2015-06-03 CN disclosed
US-20140349339-A1 PmST3 ENZYME FOR CHEMOENZYMATIC SYNTHESIS OF ALPHA-2-3-SIALOSIDES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2014-11-27 US disclosed
US-20100324271-A1 PHAGE-DISPLAYING SINGLE-CHAIN ANTIBODY CAPABLE OF RECOGNIZING NON-REDUCED MANNOSE RESIDUE TOKAI UNIVERSITY EDUCATIONAL SYSTEM (JP) 2010-12-23 US disclosed
EP-2022854-A1 PHAGE-DISPLAYING SINGLE-CHAIN ANTIBODY CAPABLE OF RECOGNIZING NON-REDUCED MANNOSE RESIDUE TOKAI UNIVERSITY EDUCATIONAL SYSTEM (JP) 2009-02-11 EP disclosed
US-6387372-B1 DIAGNOSIS OF PARATUBERCULOSIS IN CATTLE AND CROHN'S DISEASE IN HUMANS; N.V. INNOGENETICS S.A. (BE) 2002-05-14 US disclosed
EP-0577666-B1 POLYPEPTIDES FROM MYCOBACTERIUM PARATUBERCULOSIS INNOGENETICS NV (BE) 2000-10-18 EP disclosed
US-5888799-A Recombinant avirulent bacterial antigen delivery system RESEARCH CORPORATION TECHNOLOGIES, INC. (US) 1999-03-30 US disclosed
EP-0577666-A1 POLYPEPTIDES FROM MYCOBACTERIUM PARATUBERCULOSIS N.V. INNOGENETICS S.A. (BE) 1994-01-12 EP disclosed
WO-1992016628-A1 POLYPEPTIDES FROM MYCOBACTERIUM PARATUBERCULOSIS N.V. INNOGENETICS S.A. (BE) 1992-10-01 WO disclosed
US-4888170-A Vaccines obtained from antigenic gene products of recombinant genes RESEARCH CORPORATION (US) 1989-12-19 US disclosed